Home > CF Guidelines > Devices & Procedures Spirometry  
Search www.PenCF.org.uk for information




Bowel Roll Over
Chest Roll Over
Consensus Roll Over
Devies Roll Over
Gastrostomy Care Roll Over
Gastrostomy Tube Reaplcement Roll OVer
Home IV Roll Over
Nebulised Drug Chalenge Roll Over
Nebulisers
Preparation for Surgery Roll OVer
Spirometry Roll Over
Sweat Test Roll Over
Tivad Care Roll Over
Transition Roll Over
Travelling Abroad Roll OVer
Venous Access Roll Over
Medications Roll Over

Other Roll OVer




   
CF Guidelines - Spirometry
               
    Spirometry in Cystic Fibrosis:
        All patients over the age of 5 should have regular lung function testing. This should include FEV1, FVC, FEV1/FVC, PEFR, FEF25-75. This should be done as a minimum every three months during clinic visits. Spirometry should also be performed at the start, midway and at the end of every IV antibiotic treatment and at any other time deemed appropriate.
               
    Guidelines for performing spirometry:
     
-
Spirometry should be performed in a well ventilated room away from other CF patients.
     
-
Spirometry should be performed in the sitting position (or standing if the patient prefers).
     
-
Inpatient spirometry should be performed in the patients own room with the door shut.
     
-
Patients should be encouraged to wash or disinfect their hands before using the spirometer.
     
-
Always use a separate bacterial filter for each patient.
     
-
All filters should be disposed of in clinical waste after each patient.
     
-
The spirometer should be cleaned between each patient as specified by local infection control policy.
     
-
All spirometers should be cleaned, dried and maintained according to local policies.
     
-
All spirometers should be re-callibrated according the manufacturers instructions.
               
    Plymouth Paediatric Team Only:
        It is not practical to have separate spirometers according to patient’s bacterial status; however the following guidelines should be adhered to regarding the changing of the turbines to reduce the risk of cross infection between patients:
       
-
Patients with either Burkholderia cepacia, Multi-Resistant Pseudomonas Aeruginosa, MRSA or Stenotrophomonas maltiphilia will all have their own turbine.
       
-
Individual turbines will be identified for use with either Pseudomonas negative or Pseudomonas positive patients.
       
-
Turbines should be cleaned according to local infection control policies.
       
-
Spirometers should be calibrated every time a new turbine is used.
               
        Dowloadable PDF File - PDF File    
           
           
               
         
           
Document approved - 2011
           
Document due for review - December 2013
               
        Acknowledgements: The Peninsula CF team acknowledges the use of guidelines produced by The CF Trust, Manchester, Papworth, Leeds and Brompton CF teams during development of these local Peninsula protocols and guidelines.
               
Disclaimer: While efforts have been made to ensure that all the information published on this web site is correct, the authors take no responsibility for the accuracy of information, or for harm arising as a consequence of errors contained within this web site. If you have concerns regarding treatment, drugs or doses then consult your local CF consultant.